Three hematological indexes that may serve as prognostic indicators in patients with primary, high-grade, appendicular osteosarcoma

Keqi Hu; Zhan Wang; Peng Lin; Haiyong Ren; Lingling Sun; Hengyuan Li; Binghao Li; Shengdong Wang; Siyuan Tengwang; Xingzhi Zhou; Zhaoming Ye

doi:10.18632/oncotarget.17811

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Three hematological indexes that may serve as prognostic indicators in patients with primary, high-grade, appendicular osteosarcoma

Keqi Hu, Zhan Wang, Peng Lin, Haiyong Ren, Lingling Sun, Hengyuan Li, Binghao Li, Shengdong Wang, Siyuan Tengwang, Xingzhi Zhou and Zhaoming Ye _

PDF | HTML | How to cite

Oncotarget. 2017; 8:43130-43139. https://doi.org/10.18632/oncotarget.17811

Metrics: PDF 1505 views | HTML 1959 views | ?

Abstract

Keqi Hu1,*, Zhan Wang1,*, Peng Lin1,*, Zuojun Wen1, Haiyong Ren2, Lingling Sun1, Hengyuan Li1, Binghao Li1, Shengdong Wang1, Xingzhi Zhou1, Siyuan Tengwang1, Langhai Xu1 and Zhaoming Ye1

1Center for Orthopedic Research, Orthopedics Research Institute of Zhejiang University, Department of Orthopedics, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310000, China

2Department of Orthopedics, Tongde Hospital of Zhejiang Province, Hangzhou, 310000, China

*These authors have contributed equally to this work

Correspondence to:

Zhaoming Ye, email: [email protected]

Keywords: osteosarcoma, prognosis, alkaline phosphatase, lactate dehydrogenase, fibrinogen

Received: December 28, 2016 Accepted: April 19, 2017 Published: May 11, 2017

ABSTRACT

Background: Although alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) are considered effective prognostic factors of osteosarcoma, useful prognostic biomarkers for patients with osteosarcoma are still lacking.

Methods: A retrospective study of 106 patients with primary, high-grade, appendicular osteosarcoma obtained between 2006 and 2011 was performed to assess the prognostic value of serum ALP, LDH and fibrinogen (FBG) levels, as well as their decrease rates in osteosarcoma. The Kaplan-Meier method was employed to analyze overall survival. The Cox proportional hazard model was used to determine the significance of these prognostic biomarkers on survival distribution.

Results: Patients with pre-ct (before neoadjuvant chemotherapy) LDH>210U/L, post-ct (after neoadjuvant chemotherapy, but before surgery) LDH>215U/L, post-ct FBG>2.8g/L, FBG DR (Decrease Rate)≤10% tended to have a poorer prognosis.

Conclusions: High pre-ct and post-ct peripheral serum LDH level, high serum post-ct FBG level and low decrease rate of serum FBG were related to poor survival in patients with osteosarcoma. Fibrinogen was found to be a new valuable predictor of 5-year survival in patients with osteosarcoma for the first time.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17811

Publication Alerts

Research Papers:

Three hematological indexes that may serve as prognostic indicators in patients with primary, high-grade, appendicular osteosarcoma

Abstract